Dowling & Yahnke LLC Dexcom Inc Transaction History
Dowling & Yahnke LLC
- $215 Million
- Q3 2022
A detailed history of Dowling & Yahnke LLC transactions in Dexcom Inc stock. As of the latest transaction made, Dowling & Yahnke LLC holds 59,056 shares of DXCM stock, worth $4.27 Million. This represents 2.21% of its overall portfolio holdings.
Number of Shares
59,056
Previous 58,968
0.15%
Holding current value
$4.27 Million
Previous $4.4 Million
8.21%
% of portfolio
2.21%
Previous 0.21%
Shares
20 transactions
Others Institutions Holding DXCM
# of Institutions
1,075Shares Held
362MCall Options Held
4.1MPut Options Held
3.61M-
Vanguard Group Inc Valley Forge, PA46.5MShares$3.36 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.49 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.3MShares$1.18 Billion0.08% of portfolio
-
Baillie Gifford & CO15.3MShares$1.11 Billion1.38% of portfolio
-
Capital Research Global Investors Los Angeles, CA11.9MShares$863 Million0.31% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $27.9B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...